IRIS TAFOYA: Open Payments
NPI 1801365572 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$482 in 5 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $1,509 · 2025 $482
Food & beverage: $482
| Company | Payments | Amount |
|---|---|---|
| Insulet Corporation | 1 | $169 |
| Astellas Pharma US Inc | 1 | $125 |
| Novo Nordisk Inc | 1 | $117 |
| Abbott Laboratories | 1 | $56 |
| INTERNATIONAL REHABILITATIVE SCIENCES, INC | 1 | $15 |
Products named: OMNIPOD, Veozah, Ozempic, FREESTYLE LIBRE 3, RS-4i Plus with Intersperse.
Industry payments across TX — which companies pay providers there.
